Painless Vaginal Delivery

Effect of the use of dexmedetomidine as a local anesthetic adjuvant in epidural labour analgesia: Randomized controlled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201710002664704

Enrollment

Registered

2017-10-03

Start date

2017-10-12

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Painless Vaginal Delivery

Interventions

Epidural Bupivacaine alone

Epidural bupivacaine and dexmedetomidine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: -Aged from 21 to 30 years old -With more than 37 weeks of gestation -Vertex presentation -in active normal labour with cervical dilatation more than 3 cm.

Exclusion criteria

Exclusion criteria: -Patients refuse of regional anesthesia -Hemodynamically unstable -Known or suspected allergy to the used drugs -With obstetric disorders,pregnancy-induced hypertension, suspected or documented coagulopathy -Body mass index more than 35 kg/m2.

Design outcomes

Primary

Measure	Time frame
Onset of analgesia	—

Secondary

Measure	Time frame
Motor Block	—

Countries

Egypt

Contacts

Public ContactAmr Eid

Tanta Sporting Club

amr_eid_81@yahoo.com00201277735156

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026